Overview
To investigate the effect and feasibility of percutaneous acupoint stimulation combined with oxycodone on postoperative visceral pain in laparoscopic patients, and provided a clinical basis for optimizing perioperative pain management in laparoscopic patients.
Description
Patients aged 18-65 years old, BMI 18-30kg/m2, ASA grade I or II were selected for gynecologic laparoscopic surgery (laparoscopic ovarian tumor stripping, laparoscopic uterine fibroid stripping, laparoscopic total hysterectomy) under general anesthesia from May 2024 to July 2024. Exclusion criteria: Patients who were allergic to the drugs used in the study, had confusion or cognitive impairment, contraindicated percutaneous acupoint electrical stimulation, abnormal cardiopulmonary and liver and kidney function, history of analgesic drug use within one week, history of diabetes, myocardial infarction, or cerebrovascular accident. Exclusion criteria: patients dropped out of the experiment midway or the data was not completely collected, the surgical method changed midway, the operation duration was less than 30 minutes or more than 2 hours, and patients with opioid and addictive drug dependence
Eligibility
Inclusion Criteria:
- Age 18-65 years
- American Society of Anesthesiologists grade I-II
- Body mass index (BMI) 18.5-30 kg/m2;
- No ulceration or infection at the acupuncture stimulation site.
Exclusion Criteria:
- Allergic to the drugs used in the study;
- People with unclear consciousness or cognitive dysfunction;
- There are contraindications of percutaneous acupoint electrical stimulation;
- Abnormal cardiopulmonary and liver and kidney function;
- History of analgesic drug use within one week;
- History of diabetes, myocardial infarction or cerebrovascular accident.